These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3563087)

  • 1. [Antiaggregating effect of indobufen. Preliminary results of a study of 20 patients].
    Andriani A; Chiappetta MG; Mannarino E; Mosiello G; Zampa G; Beni A
    Recenti Prog Med; 1986 Dec; 77(12):580-6. PubMed ID: 3563087
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
    Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON
    Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term trial (6 months) of the platelet aggregation inhibitory activity and biological safety of indobufen in cerebrovascular patients.
    Mansi D; Majello L; Palma V; De Michele G; Buscaino GA
    Acta Neurol (Napoli); 1983 Dec; 5(6):447-55. PubMed ID: 6367383
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease].
    Liusov VA; Diukov IV; Uteshev DV
    Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases].
    Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M
    Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation in man by indobufen (K 3920).
    Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
    J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
    Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
    Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor].
    Ciammaichella A; Luzi M; Pezzi F; Recchia O
    Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen].
    Craveri A; Lanfredini M; Citella C; Braconaro F; Colombo L
    Minerva Cardioangiol; 1988 Sep; 36(9):411-8. PubMed ID: 3226570
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of in vivo platelet aggregation by indobufen in angina patients during exercise.
    Pogliani EM; Fantasia R; Perini C; Corvi G
    J Int Med Res; 1981; 9(2):113-9. PubMed ID: 7014283
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
    Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E
    Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular thrombi: changes in size and in platelet deposition during treatment with indobufen and ticlopidine.
    Bellotti P; Claudiani F; Chiarella F; Domenicucci S; Scopinaro G; Mazzotta G; Lupi G; Strada P; Vecchio C
    Cardiology; 1990; 77(4):272-9. PubMed ID: 2073644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating platelet aggregates in cerebrovascular diseases. Preliminary data.
    Carrieri P; La Pia S; Indaco A; Pisano P; Orefice G; Iadevaia V
    Acta Neurol (Napoli); 1981 Jun; 3(3):500-4. PubMed ID: 7282470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation and functions of blood platelets in patients with diabetes mellitus type 1 before and during the treatment with indobufen].
    Dmoszyńska-Giannopoulou A; Sokołowska B; Ledwozyw A
    Pol Arch Med Wewn; 1990 Mar; 83(3):97-103. PubMed ID: 2216938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
    Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P
    Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.